{
    "clinical_study": {
        "@rank": "40297", 
        "arm_group": [
            {
                "arm_group_label": "Early postpartum vitamin A suppl.", 
                "arm_group_type": "Experimental", 
                "description": "Single dose 200,000 IU vitamin A supplementation at <3-day and placebo supplementation at 6-wk postpartum."
            }, 
            {
                "arm_group_label": "Late postpartum vitamin A suppl.", 
                "arm_group_type": "Experimental", 
                "description": "Placebo supplementation at <3-day and single dose 200,000 IU vitamin A supplementation at 6-wk postpartum."
            }, 
            {
                "arm_group_label": "Early & late postpartum vitamin A suppl", 
                "arm_group_type": "Experimental", 
                "description": "200,000 IU vitamin A supplementation, both at <3-day and 6-wk postpartum"
            }, 
            {
                "arm_group_label": "No postpartum vitamin A suppl.", 
                "arm_group_type": "Experimental", 
                "description": "Placebo supplementation, both at <3-day and 6-wk postpartum."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the effect of post-partum maternal vitamin A\n      supplementation on breast milk bioactive compounds and immune status, growth and morbidity\n      of children in the first four months of life."
        }, 
        "brief_title": "Stopping Postpartum Vitamin A Supplementation: Missing Concealed Benefit", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Vitamin A Deficiency", 
        "condition_browse": {
            "mesh_term": [
                "Vitamin A Deficiency", 
                "Night Blindness"
            ]
        }, 
        "detailed_description": {
            "textblock": "The effect will be assessed by the milk and blood."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Pregnant women  >-18 years of age with low-risk obstetric\n\n        Exclusion Criteria:\n\n          -  Pregnant women expecting a multiple birth\n\n          -  Take vitamin A supplements during postpartum apart from study intervention\n\n          -  Premature birth\n\n          -  Newborn babies with birth defects and / or other serious diseases"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "32 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "128", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02043223", 
            "org_study_id": "PR-13060"
        }, 
        "intervention": [
            {
                "arm_group_label": "Early postpartum vitamin A suppl.", 
                "description": "Single dose 200,000 IU vitamin A supplementation at <3-day and placebo supplementation at 6-wk postpartum.", 
                "intervention_name": "Vitamin A (<3-day postpartum)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Late postpartum vitamin A suppl.", 
                "description": "Placebo supplementation at <3-day and single dose 200,000 IU vitamin A supplementation at 6-wk postpartum.", 
                "intervention_name": "Vitamin A (6 wk postpartum)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Early & late postpartum vitamin A suppl", 
                "description": "200,000 IU vitamin A supplementation, both at <3-day and 6-wk postpartum", 
                "intervention_name": "Vitamin A (<3-day and 6 wk postpartum)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "No postpartum vitamin A suppl.", 
                "description": "Placebo supplementation, both at <3-day and 6-wk postpartum.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin A", 
                "Vitamins", 
                "Retinol palmitate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Vitamin A", 
            "Breast milk", 
            "Postpartum vitamin A supplementation", 
            "Infant vaccine response"
        ], 
        "lastchanged_date": "January 19, 2014", 
        "location": {
            "contact": {
                "email": "smeahmad@icddrb.org", 
                "last_name": "Shaikh M Ahmad, Ph.D", 
                "phone": "+88029827001-10", 
                "phone_ext": "3469"
            }, 
            "contact_backup": {
                "email": "rubhana@icddrb.org", 
                "last_name": "Raqib Rubhana, Ph.D", 
                "phone": "+88029827001-10", 
                "phone_ext": "2404"
            }, 
            "facility": {
                "address": {
                    "city": "Dhaka", 
                    "country": "Bangladesh", 
                    "zip": "1212"
                }, 
                "name": "International Centre for Diarrhoeal Disease Research, Bangladesh"
            }, 
            "investigator": {
                "last_name": "Shaikh M Ahmad, Ph.D", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Bangladesh"
        }, 
        "number_of_arms": "4", 
        "official_title": "Stopping Postpartum Vitamin A Supplementation: Are we Missing Concealed Benefit?", 
        "other_outcome": [
            {
                "description": "Infant plasma vitamin A status at 7 wk and 15 wk of age", 
                "measure": "Infant vitamin A status", 
                "safety_issue": "No", 
                "time_frame": "Four months"
            }, 
            {
                "description": "Infant Weight-for-Age z-score (WAZ) at 7 wk and 15 wk of age", 
                "measure": "Infant growth", 
                "safety_issue": "No", 
                "time_frame": "Four months"
            }, 
            {
                "description": "Infant morbidity status up to four months of age", 
                "measure": "Infant morbidity", 
                "safety_issue": "No", 
                "time_frame": "Four months"
            }
        ], 
        "overall_contact": {
            "email": "smeahmad@icddrb.org", 
            "last_name": "Shaikh M Ahmad, Ph.D", 
            "phone": "+88029827001-10", 
            "phone_ext": "3469"
        }, 
        "overall_contact_backup": {
            "email": "rubhana@icddrb.org", 
            "last_name": "Raqib Rubhana, Ph.D", 
            "phone": "+88029827001-10", 
            "phone_ext": "2404"
        }, 
        "overall_official": {
            "affiliation": "International Centre for Diarrhoeal Disease Research, Bangladesh", 
            "last_name": "Shaikh M Ahmad, Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Bangladesh: Ethical Review Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "At three time points-\n< 3-day postpartum (before supplementation)\n7 wk postpartum (1wk after 2nd dose of supplementation)\n15 wk postpartum", 
                "measure": "Breast milk TGF-beta", 
                "safety_issue": "No", 
                "time_frame": "Four months"
            }, 
            {
                "description": "At three time points-\n< 3-day postpartum (before supplementation)\n7 wk postpartum (1wk after 2nd dose of supplementation)\n15 wk postpartum", 
                "measure": "Breast milk secretory IgA (sIgA)", 
                "safety_issue": "No", 
                "time_frame": "Four months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02043223"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "PHA stimulated whole blood IL-10, IL-13, IFN-gamma and IL-17 responses at two time points-\n7 wk of age (1wk after 2nd dose of maternal supplementation , as well as, 1wk after first doses of pentavalent vaccination)\n15 wk of age (1wk after three doses of pentavalent vaccination)", 
                "measure": "Infant T helper cell immune responses", 
                "safety_issue": "No", 
                "time_frame": "Four months"
            }, 
            {
                "description": "Tall like receptor (TLR)-4 and TLR9 agonist stimulated whole blood TNF-alpha and IL-10 and IFN-alpha responses at two time points-\n7 wk of age (1wk after 2nd dose of maternal supplementation , as well as, 1wk after first doses of pentavalent vaccination)\n15 wk of age (1wk after three doses of pentavalent vaccination)", 
                "measure": "Infant innate immune responses", 
                "safety_issue": "No", 
                "time_frame": "Four months"
            }
        ], 
        "source": "International Centre for Diarrhoeal Disease Research, Bangladesh", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Peter Bergman, MD, PhD", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Karolinska University Hospital, Huddinge, Sweden", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "International Centre for Diarrhoeal Disease Research, Bangladesh", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}